| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/28/2010 | US7803903 Protein-binding doxorubicin peptide derivatives |
| 09/28/2010 | US7803775 Kit comprising inhibitory peptide for use in reducing side effects of drug cessation |
| 09/28/2010 | US7803774 retro-inverso isomers of beta-amyloid peptides, used for diagnosis and treatment of amyloidogenic diseases such as Alzheimer's disease |
| 09/28/2010 | US7803765 production and of nucleic acid fragment libraries that express highly diverse peptides, polypeptides or protein domains and, in particular, nucleic acid fragment libraries wherein the nucleic acid fragments are derived from two or more prokaryote genomes or compact eukaryote genomes |
| 09/28/2010 | US7803757 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide |
| 09/28/2010 | US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response |
| 09/28/2010 | US7803739 Substrates and assays for β-secretase |
| 09/28/2010 | US7803571 Using insulin receptor substrate peptides as diagnostic tool in identifying modulators of protein kinase activity; enzyme inhibitor; mimetics |
| 09/28/2010 | US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 09/28/2010 | US7803524 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates |
| 09/28/2010 | US7803381 Synthetic peptide comprising the amino acid sequence GPRLGYSWHX in which each of the amino acids are in the D-amino acid configuration and X is any amino acid; optionally conjugated to the natural gonadotropin-releasing hormone peptide; vaccines for use incontrolling fertility or heat in an animal |
| 09/28/2010 | CA2238050C Inhibitors of cyclophilin rotamase activity |
| 09/23/2010 | WO2010108164A2 Novel anti-parasitic compounds |
| 09/23/2010 | WO2010107832A1 Lhrh-ii peptide analogs |
| 09/23/2010 | WO2010107116A1 Hla-a24-binding cancer antigen peptide derived from sox2 |
| 09/23/2010 | WO2010106770A1 Neil3 peptides and vaccines including the same |
| 09/23/2010 | WO2010106441A2 Peptidomimetics for modulating interleukin-1 receptor |
| 09/23/2010 | WO2010106437A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same |
| 09/23/2010 | WO2010106293A1 Analogs of temporin-sha, and uses thereof |
| 09/23/2010 | WO2010105636A1 Topical compositions comprising interleukin-1 alpha and peptides and cosmetic methods thereof |
| 09/23/2010 | WO2010105363A1 Cyclic amino acid molecules and methods of preparing the same |
| 09/23/2010 | US20100242137 Polynucleotides encoding proteins involved in plant metabolism |
| 09/23/2010 | US20100240866 Modified gherlin peptides |
| 09/23/2010 | US20100240865 Process for production of cyclic peptides |
| 09/23/2010 | US20100240731 Lipopeptides for delivery of nucleic acids |
| 09/23/2010 | US20100240598 Peptides and peptide mimetics to inhibit the onset and/or progression of fibrotic and/or pre-fibrotic pathologies |
| 09/23/2010 | US20100240594 Targeted delivery of chemotherapeutic agents |
| 09/23/2010 | US20100240592 Template-fixed peptidomimetics with antimicrobial activity |
| 09/23/2010 | US20100240590 Peptides and related molecules that bind to tall-1 |
| 09/23/2010 | US20100240589 Diastereomeric peptides useful as inhibitors of membrane protein assembly |
| 09/23/2010 | US20100240582 Peptides and related molecules that modulate nerve growth factor activity |
| 09/23/2010 | US20100240080 Kinase and phosphatase assays |
| 09/23/2010 | US20100240072 Cancer Imaging and Treatment |
| 09/23/2010 | US20100240066 Compounds and methods for modulating cadherin-mediated processes |
| 09/23/2010 | US20100239653 Pharmaceutical preparations and methods for inhibiting tumors |
| 09/23/2010 | US20100239611 Combination adjuvant formulation |
| 09/23/2010 | US20100239564 Novel human growth factors |
| 09/23/2010 | US20100239548 Isolation and Identification of T Cells |
| 09/23/2010 | US20100239547 Synthetic hla binding peptide analogues and uses thereof |
| 09/23/2010 | US20100239503 Calcium-binding agents induce hair growth and/or nail growth |
| 09/23/2010 | CA2793800A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same |
| 09/23/2010 | CA2793683A1 Peptidomimetics for modulating interleukin-1 receptor |
| 09/23/2010 | CA2756804A1 Cyclic amino acid molecules and methods of preparing the same |
| 09/23/2010 | CA2755866A1 Inhibitors of viral integrase and methods of use |
| 09/23/2010 | CA2755722A1 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents |
| 09/23/2010 | CA2755472A1 Analogs of temporin-sha, and uses thereof |
| 09/23/2010 | CA2755342A1 Neil3 peptides and vaccines including the same |
| 09/22/2010 | EP2230309A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 09/22/2010 | EP2230303A1 Isolating biological modulators from biodiverse gene fragment libraries |
| 09/22/2010 | EP2229408A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 09/22/2010 | EP2229403A1 Recovery of hydrophobic peptides from oils |
| 09/22/2010 | EP2229402A1 Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies |
| 09/22/2010 | EP2229401A1 Production and use of antitumoral cyclodepsipeptides |
| 09/22/2010 | EP2229400A1 Advantageous salts of mu-opiate receptor peptides |
| 09/22/2010 | EP2229399A1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 09/22/2010 | EP2229398A2 Control of transport properties to and from nanoparticle surfaces |
| 09/22/2010 | EP1601384B1 Methods of radiofluorination of biologically active vectors |
| 09/22/2010 | CN1612746B Use of HEPCIDIN as a regulator of iron homeostasis |
| 09/22/2010 | CN101838650A Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody |
| 09/22/2010 | CN101838314A Preparation of cyclic lipopeptide compound and application thereof |
| 09/22/2010 | CN101838313A Mimic short peptide 9B of endothelial cell growth factor VEGF antigen epitope and application thereof |
| 09/22/2010 | CN101838312A Mimic short peptide 12B of endothelial cell growth factor VEGF antigen epitope and application thereof |
| 09/22/2010 | CN101838311A Mimic short peptide 7B of endothelial cell growth factor VEGF antigen epitope and application thereof |
| 09/22/2010 | CN101838310A Basic fibroblast growth factor epitope simulative peptide T3 and application thereof |
| 09/22/2010 | CN101838309A Solid-phase synthesis of momordica charantia MC-JJ0102 polypeptide analogue under microwave irradiation and application thereof |
| 09/22/2010 | CN101838308A Solid-phase synthesis method for eptifibatide |
| 09/22/2010 | CN101838307A K2 polypeptide synthesis product and application thereof |
| 09/22/2010 | CN101838306A K4 polypeptide synthesis product and application thereof |
| 09/22/2010 | CN101838305A T2 peptide synthesis product and application thereof |
| 09/22/2010 | CN101837124A Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 09/21/2010 | US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/21/2010 | US7799561 Affinity peptides and method for purification of recombinant proteins |
| 09/21/2010 | CA2445068C Azo compounds for type i phototherapy |
| 09/21/2010 | CA2309356C Novel exendin agonist compounds |
| 09/21/2010 | CA2225675C Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| 09/16/2010 | WO2010104696A1 Method and composition for the treatment of moderate to severe keratoconjunctivitis sicca |
| 09/16/2010 | WO2010103926A1 Method for mixing substance into gel assembly |
| 09/16/2010 | WO2010103887A1 Self-assembling peptide and peptide gel with high strength |
| 09/16/2010 | WO2010103254A1 Peptide promoting cell adhesion and migration |
| 09/16/2010 | WO2010103204A1 Metal ion chelating agents, methods for preparing same and uses thereof |
| 09/16/2010 | WO2010085039A3 Noggin-derived peptide and use thereof |
| 09/16/2010 | WO2010057242A3 Vaccine |
| 09/16/2010 | WO2010054108A3 Cas6 polypeptides and methods of use |
| 09/16/2010 | WO2010009319A3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| 09/16/2010 | US20100234563 Methods for Preparing Internally Constrained Peptides and Peptidomimetics |
| 09/16/2010 | US20100234306 Use of a peptide as a therapeutic agent |
| 09/16/2010 | US20100234304 Beta sheet tapes ribbons in tissue engineering |
| 09/16/2010 | US20100234303 Agents, methods and uses |
| 09/16/2010 | US20100234302 Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus |
| 09/16/2010 | US20100234301 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 09/16/2010 | US20100234300 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically |
| 09/16/2010 | US20100234246 Method for producing peptide libraries and use thereof |
| 09/16/2010 | US20100233819 Robo: a novel family of polypeptides and nucleic acids |
| 09/16/2010 | US20100233783 Novel method for protein purification |
| 09/16/2010 | US20100233737 Marker specific to an oxidative degradation of tissues containing type iii collagen, means and methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by this marker |
| 09/16/2010 | US20100233711 Gene encoding labyrinthin, a marker for cancer |
| 09/16/2010 | US20100233676 High affinity fluorochrome binding peptides |
| 09/16/2010 | US20100233176 Methods and systems for predicting misfolded protein epitopes |
| 09/16/2010 | US20100233161 Novel multifunctional compounds for pharmaceutical purposes |
| 09/16/2010 | US20100233146 Coatings and Surface Treatments Having Active Enzymes and Peptides |